Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells.
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Recently, angiotensin II (Ang II) has been shown to cause hypertrophy of cultured quiescent rat aortic smooth muscle (RASM) cells. This observation along with the demonstration of angiotensinogen mRNA in the vessel wall has led us to postulate a role for vascular angiotensin in hypertensive blood vessel hypertrophy. To investigate further the possible molecular mechanisms, we examined the effect of Ang II on the expression of two genes known to be involved with cellular growth response. Near-confluent RASM cells were made quiescent by 48-h exposure to a defined serum-free medium. Ang II (10(-6) to 10(-11) M) resulted in an induction of the protooncogene c-myc mRNA within 30 min which persisted for 6 h. Interestingly, 6 h after the addition of Ang II, platelet-derived growth factor (PDGF) A-chain mRNA expression was elevated, peaked in 9 h, and persisted for 11 h. This was accompanied with a 15-20-fold increase in PDGF concentration in the culture medium. These effects were dose-dependent and were blocked by saralasin. Whereas the inhibition of protein synthesis by cycloheximide resulted in a stabilization of c-myc mRNA, cycloheximide abolished the elevation of the PDGF A-chain mRNA. Taken together, our data show that exposure of RASM cells to Ang II results in the sequential activation of c-myc and PDGF A-chain mRNA expressions. This sequential activation of protooncogene and growth factor gene may be an important mechanism in angiotensin-induced smooth muscle growth and hypertrophy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,887
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,725
Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene
Greenberg, M. E., & Ziff, E. B. (1984) · Nature · doi:10.1038/311433a0 · Cited by 3,064
Induction of c-fos gene and protein by growth factors precedes activation of c-myc
Müller, R., Bravo, R., Burckhardt, J., & Curran, T. (1984) · Nature · doi:10.1038/312716a0 · Cited by 1,369
Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells.
Geisterfer, A. A., Peach, M. J., & Owens, G. K. (1988) · Circulation Research · doi:10.1161/01.res.62.4.749 · Cited by 1,065
Greenberg, M. E., Greene, L. A., & Ziff, E. B. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38689-1 · Cited by 875
Betsholtz, C., Johnsson, A., Heldin, C.-H., Westermark, B., Lind, P., Urdea, M. S., Eddy, R., Shows, T. B., Philpott, K., Mellor, A. L., et al. (1986) · Nature · doi:10.1038/320695a0 · Cited by 781
Heldin, C. H., Bäckström, G., Ostman, A., Hammacher, A., Rönnstrand, L., Rubin, K., Nistér, M., & Westermark, B. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb02955.x · Cited by 498
Folkow, B., Hallbäck, M., Lundgren, Y., Sivertsson, R., & Weiss, L. (1972) · Spontaneous Hypertension · doi:10.1007/978-3-642-65441-1_23 · Cited by 497
Cultured endothelial cells produce a platelet-derived growth factor-like protein
DiCorleto, P. E., & Bowen-Pope, D. F. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.7.1919 · Cited by 497
Cited by
Sadoshima, J., & Izumo, S. (1993) · Circulation Research · doi:10.1161/01.res.73.3.413 · Cited by 1,427
Kagami, S., Border, W. A., Miller, D. E., & Noble, N. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117251 · Cited by 1,076
Molecular and Cellular Mechanisms of Angiotensin II-Mediated Cardiovascular and Renal Diseases
Kim, S., & Iwao, H. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01434-0 · Cited by 983
Touyz, R. M., & Schiffrin, E. L. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01471-6 · Cited by 934
Mukoyama, M., Nakajima, M., Horiuchi, M., Sasamura, H., Pratt, R. E., & Dzau, V. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74498-6 · Cited by 768
Self-citationTissue Angiotensin and Pathobiology of Vascular Disease: A Unifying Hypothesis
Dzau, V. J. (2001) · Hypertension · doi:10.1161/01.hyp.37.4.1047 · Cited by 750
Self-citationDirect stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor
Marrero, M. B., Schieffer, B., Paxton, W. G., Heerdt, L., Berk, B. C., Delafontaine, P., & Bernstein, K. E. (1995) · Nature · doi:10.1038/375247a0 · Cited by 745
NITRIC OXIDE SYNTHASE: Role in the Genesis of Vascular Disease
Cooke, M., & Dzau, M. (1997) · Annual Review of Medicine · doi:10.1146/annurev.med.48.1.489 · Cited by 710
Gibbons, G. H., Pratt, R. E., & Dzau, V. J. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115881 · Cited by 645
Self-citationSchunkert, H., Dzau, V. J., Tang, S. S., Hirsch, A. T., Apstein, C. S., & Lorell, B. H. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114924 · Cited by 606
Self-citationEguchi, S., Numaguchi, K., Iwasaki, H., Matsumoto, T., Yamakawa, T., Utsunomiya, H., Motley, E. D., Kawakatsu, H., Owada, K. M., Hirata, Y., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.15.8890 · Cited by 566
Forrester, J. S., Fishbein, M., Helfant, R., & Fagin, J. (1991) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(10)80196-2 · Cited by 557
Regulation of differentiated properties and proliferation of arterial smooth muscle cells.
Thyberg, J., Hedin, U., Sjölund, M., Palmberg, L., & Bottger, B. A. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.6.966 · Cited by 553
(1992) · Circulation · doi:10.1161/01.cir.86.1.100 · Cited by 539
Renal injury from angiotensin II-mediated hypertension.
Johnson, R. J., Alpers, C. E., Yoshimura, A., Lombardi, D., Pritzl, P., Floege, J., & Schwartz, S. M. (1992) · Hypertension · doi:10.1161/01.hyp.19.5.464 · Cited by 536
Expression of AT2 receptors in the developing rat fetus.
Grady, E. F., Sechi, L. A., Griffin, C. A., Schambelan, M., & Kalinyak, J. E. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115395 · Cited by 535
Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.
Lonn, E. M., Yusuf, S., Jha, P., Montague, T. J., Teo, K. K., Benedict, C. R., & Pitt, B. (1994) · Circulation · doi:10.1161/01.cir.90.4.2056 · Cited by 503
Angiotensin Induces Inflammatory Activation of Human Vascular Smooth Muscle Cells
Kranzhöfer, R., Schmidt, J., Pfeiffer, C. A. H., Hagl, S., Libby, P., & Kübler, W. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.7.1623 · Cited by 480
Itoh, H., Mukoyama, M., Pratt, R. E., Gibbons, G. H., & Dzau, V. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116454 · Cited by 469
Self-citationIncreased Accumulation of Tissue ACE in Human Atherosclerotic Coronary Artery Disease
Diet, F., Pratt, R. E., Berry, G. J., Momose, N., Gibbons, G. H., & Dzau, V. J. (1996) · Circulation · doi:10.1161/01.cir.94.11.2756 · Cited by 426
Self-citationAntiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit.
Chobanian, A. V., Haudenschild, C. C., Nickerson, C., & Drago, R. (1990) · Hypertension · doi:10.1161/01.hyp.15.3.327 · Cited by 411
Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death
MARIAN, A. (1993) · The Lancet · doi:10.1016/0140-6736(93)92064-z · Cited by 409
Brilla, C. G., Janicki, J. S., & Weber, K. T. (1991) · Circulation Research · doi:10.1161/01.res.69.1.107 · Cited by 409
The renin-angiotensin-aldosterone system: a specific target for hypertension management
Weir, M. (1999) · American Journal of Hypertension · doi:10.1016/s0895-7061(99)00103-x · Cited by 407
Cyclophilin A Is a Secreted Growth Factor Induced by Oxidative Stress
Jin, Z.-G., Melaragno, M. G., Liao, D.-F., Yan, C., Haendeler, J., Suh, Y.-A., Lambeth, J. D., & Berk, B. C. (2000) · Circulation Research · doi:10.1161/01.res.87.9.789 · Cited by 398
Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism.
Griffin, S. A., Brown, W. C., MacPherson, F., McGrath, J. C., Wilson, V. G., Korsgaard, N., Mulvany, M. J., & Lever, A. F. (1991) · Hypertension · doi:10.1161/01.hyp.17.5.626 · Cited by 391
Wolf, G., Mueller, E., Stahl, R. A., & Ziyadeh, F. N. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116710 · Cited by 379
Han, Y., Runge, M. S., & Brasier, A. R. (1999) · Circulation Research · doi:10.1161/01.res.84.6.695 · Cited by 377
Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass.
Lafayette, R. A., Mayer, G., Park, S. K., & Meyer, T. W. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115949 · Cited by 348
Niimura, F., Labosky, P. A., Kakuchi, J., Okubo, S., Yoshida, H., Oikawa, T., Ichiki, T., Naftilan, A. J., Fogo, A., & Inagami, T. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118366 · Cited by 337
Self-citationAtrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells.
Itoh, H., Pratt, R. E., & Dzau, V. J. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114893 · Cited by 326
Self-citationTakemoto, M., Egashira, K., Usui, M., Numaguchi, K., Tomita, H., Tsutsui, H., Shimokawa, H., Sueishi, K., & Takeshita, A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119156 · Cited by 325
Williams, B., Baker, A. Q., Gallacher, B., & Lodwick, D. (1995) · Hypertension · doi:10.1161/01.hyp.25.5.913 · Cited by 301
Abnormalities of the Extracellular Degradation of Collagen Type I in Essential Hypertension
Laviades, C., Varo, N., Fernández, J., Mayor, G., Gil, M. J., Monreal, I., & Díez, J. (1998) · Circulation · doi:10.1161/01.cir.98.6.535 · Cited by 298
How much is too much? Interleukin-6 and its signalling in atherosclerosis
Schuett, H., Luchtefeld, M., Grothusen, C., Grote, K., & Schieffer, B. (2009) · Thrombosis and Haemostasis · doi:10.1160/th09-05-0297 · Cited by 289
Fibrosis in diabetes complications: Pathogenic mechanisms and circulating and urinary markers
Twigg, S. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.s1991 · Cited by 286
Benetos, A., Gautier, S., Ricard, S., Topouchian, J., Asmar, R., Poirier, O., Larosa, E., Guize, L., Safar, M., Soubrier, F., et al. (1996) · Circulation · doi:10.1161/01.cir.94.4.698 · Cited by 271
Otani, A., Takagi, H., Suzuma, K., & Honda, Y. (1998) · Circulation Research · doi:10.1161/01.res.82.5.619 · Cited by 266
Eguchi, S., Matsumoto, T., Motley, E. D., Utsunomiya, H., & Inagami, T. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.24.14169 · Cited by 261
Feener, E. P., Northrup, J. M., Aiello, L. P., & King, G. L. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117786 · Cited by 255
Lee, A. A., Dillmann, W. H., McCulloch, A. D., & Villarreal, F. J. (1995) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(95)91983-x · Cited by 255
Tissue Renin-Angiotensin System in Myocardial Hypertrophy and Failure
Dzau, V. J. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.153.8.937 · Cited by 255
Self-citationInhibiting the Effects of Angiotensin on Cardiovascular Hypertrophy
Metsärinne, K. P., Stoll, M., Falkenhahn, M., Gohlke, P., & Unger, T. (1994) · Angiotensin Receptors · doi:10.1007/978-1-4615-2464-9_13 · Cited by 6
Metadata
- Authors
- Naftilan, A. J., Pratt, R. E., & Dzau, V. J.
- Venue
- Journal of Clinical Investigation
- Published
- 1989-04-01
- Volume
- 83
- Issue
- 4
- Pages
- 1419-1424
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1990132316
- Cited by
- 623
- References
- 31
- FWCI
- 36.41
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.